|
Order hotline 888-567-3443 |
|
|
|
|
|
| MN8 Surveys & Trials |
 |
|
 |
I have been asked by LadyCare Lifetime Limited to submit my professional opinion and overview of the data, submitted here with.
As well as a Doctor of Pharmacology (PhD) I am a Medical Doctor and a Member of The Royal College of Physicians (MRCP) UK, I run a private Medical clinic on London's Harley Street specialising in non-invasive medicine.
My staff and I carried out all the trials independently within our clinical environment. Furthermore, all of the data was analysed by an independent third party statistician.
Mn8
A randomized double blind placebo controlled trial (published in the peer-reviewed journal, JACM, in 2005), demonstrated the following:
- There was a significant reduction (p< 0.02) in pain in the MN8 group compared to the placebo group
- 70% of the subjects in the MN8 group had at least a 50% reduction in pain
- 47% of whom had a > 75% reduction in pain
- 26% obtained complete pain relief with various combinations of conventional therapies.
- 18% of women experienced some side effects after taking painkillers. (dizziness, drowsiness, tiredness, light-headedness, nausea and upset stomach)
- MN8 - NO SIDE EFFECTS WERE REPORTED
- 71% reported a decrease in irritability
- 58% reported a reduction in PMS symptoms
- 54% reported a reduction in water retention and bloating
- 38% noticed a reduction in spots
Furthermore, a survey of 193 longer-term users of MN8 (the survey was conducted to establish the longer-term efficacy and safety of MN8). All were women who had Primary dysmenorrhoea with an average duration of 11.6 years i.e. they were all fairly long-term suffers of period pain.
The survey demonstrated the following:
- Average pain level was 8.2 + 0.11 on a rating scale of 1-10
- MN8 caused a statistically significant reduction (p < 0.0001) in pain level
- MN8 led to a significant reduction consumption of painkillers (p < 0.0001)
- MN8 led to a significant reduction in irritability (p< 0.0001)
- MN8 caused a significant reduction in breast tenderness (p< 0.0001)
- MN8 caused a significant reduction in bloating and water retention (p<0.0001)
- Mn8 led to a significant reduction in spots (p<0.0001)
- MN8 use led to a significant (p<0.0001) reduction of 54% in time taken off work
- 90% of those using MN8 for more than 1 year were still having pain relief
- NO LONGTERM USE SIDE EFFECTS OBSERVED were observed with long-term use of MN8
Yours sincerely,
DR NYJON. K. ECCLES BSc MBBS MRCP PhD
|
|
|
|
|
|
|
|
|
